• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Election 2026
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Election 2026
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Matthew Perrone

    Matthew Perrone

    FDA approves breakthrough hepatitis C drug
    News

    FDA approves breakthrough hepatitis C drug

    Matthew Perrone -
    December 6, 2013 10:49 pm
    0
    This image provided by 23andMe shows the company's logo. Genetic testing company 23andMe is facing a class action lawsuit, Monday, Dec. 3, 2013, alleging that the Silicon Valley startup misled customers with advertising for its personalized DNA test kit. (AP Photo/23andMe)
    News

    23andMe faces class action lawsuit in California

    Matthew Perrone -
    December 3, 2013 10:11 pm
    0
    FILE - In this file photo made June 30, 2010 three Avandia pills are displayed near the bottle in Palo Alto, Calif. The Food and Drug Administration said Monday, Nov. 25, 2013, it is lifting severe safety restrictions on the former blockbuster diabetes pill Avandia, citing recent data suggesting that the much-debated medication does not increase the risk of heart attack. (AP Photo/Paul Sakuma, File)
    News

    FDA overturns safety limits on diabetes drug

    Matthew Perrone -
    November 25, 2013 9:55 pm
    0
    This image provided 23andMe shows the company's logo. The U.S. Food and Drug Administration is ordering genetic test maker 23andMe Monday, Nov. 25, 2013, to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science. (AP Photo/23andMe)
    News

    FDA tells 23andMe to halt sales of genetic test

    Matthew Perrone -
    November 25, 2013 8:19 pm
    0
    Drug sales to hit lowest growth rate in decades
    News

    Drug sales to hit lowest growth rate in decades

    Matthew Perrone -
    November 19, 2013 3:06 pm
    0
    Bulk mixers of prescribed drugs get more scrutiny
    News

    Bulk mixers of prescribed drugs get more scrutiny

    Matthew Perrone -
    November 18, 2013 11:45 pm
    0
    Sen. David Vitter, R-La., walks to the Senate at the Capitol in Washington, Tuesday, Nov. 12, 2013. Vitter cast the lone vote in opposition to a bill designed to tighten government oversight of pharmacies that custom-mix prescription drugs, a measure to make lawmakers disclose which of their aides are enrolling in the president's new health care program as part of an ongoing effort to discredit
    News

    Senate votes to advance specialty pharmacy bill

    Associated Press, Matthew Perrone -
    November 13, 2013 12:41 am
    0
    Health overhaul debate snags Senate pharmacy bill
    News

    Health overhaul debate snags Senate pharmacy bill

    Matthew Perrone -
    November 11, 2013 10:19 pm
    0
    FDA enlists companies to head off drug shortages
    News

    FDA enlists companies to head off drug shortages

    Matthew Perrone -
    October 31, 2013 6:16 pm
    0
    FDA approves more powerful, pure hydrocodone drug
    Healthcare

    FDA approves more powerful, pure hydrocodone drug

    Matthew Perrone -
    October 25, 2013 9:32 pm
    0
    1...789...16Page 8 of 16
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.